|
Universities fertile ground for biotech research
Sunday, October 26, 2008 - 10:05 AM - 3 weeks, 4 days ago - Newspaper & TV news - FT.com - Drugs and Healthcare They may be part of a university campus but the pink shirts and striped suits mark Fusion IP as different from the academics around them |
|
Sales of MS drug lifts revenues at Elan
Thursday, October 23, 2008 - 03:44 PM - 3 weeks, 6 days ago - Newspaper & TV news - FT.com - Drugs and Healthcare Quarterly sales of Tysabri, used to treat MS and Crohn's disease, have increased from less than $8m in 2006 to $237m (£147m) in the last quarter, with more than 35,000 patients now taking the drug |
|
Sanofi-Aventis weight loss drug pulled by EU
Thursday, October 23, 2008 - 01:16 PM - 4 weeks ago - Newspaper & TV news - FT.com - Drugs and Healthcare Regulators call for Acomplia to be withdrawn from the market following a decision that the risks outweigh the benefits of taking the medication |
|
Eli Lilly reports loss after Zyprexa charge
Thursday, October 23, 2008 - 09:04 AM - 4 weeks ago - Newspaper & TV news - FT.com - Drugs and Healthcare Eli Lilly reported a third quarter loss related to a charge to settle investigations of its top-selling drug, while its rival Bristol-Myers Squibb said profit tripled in the quarter because of a big gain from selling its high-tech wound care business |
|
Bloomberg health foray
Wednesday, October 22, 2008 - 10:52 PM - 4 weeks ago - Newspaper & TV news - FT.com - Drugs and Healthcare The group will join forces with an online network for doctors to launch a service allowing investors in pharmaceutical companies to monitor and solicit physicians' opinions |
|
Drugs pricing shake-up descends into chaos
Wednesday, October 22, 2008 - 10:17 PM - 4 weeks ago - Newspaper & TV news - FT.com - Drugs and Healthcare The Department of Health warns of a three month delay in introducing a new system for setting the price of prescription medicines, potentially costing the health service millions |
|
GSK to publish level of doctors' advisory fees
Wednesday, October 22, 2008 - 12:54 PM - 4 weeks, 1 day ago - Newspaper & TV news - FT.com - Drugs and Healthcare GlaxoSmithKline is to make public the level of advisory fees it offers to doctors and medical academics, and will strictly cap the payments they can receive in the US to $150,000 (£88,000) a year each |
|
Merck cuts more jobs as profits fall
Wednesday, October 22, 2008 - 12:31 PM - 4 weeks, 1 day ago - Newspaper & TV news - FT.com - Drugs and Healthcare Merck, the US pharmaceutical group, said it would cut its global workforce by more than 10 per cent as it slashed full-year profit forecasts and reported a 28 per cent slump in third-quarter earnings |
|
Gates Foundation gives $10.4m to research
Wednesday, October 22, 2008 - 05:20 AM - 4 weeks, 1 day ago - Newspaper & TV news - FT.com - Drugs and Healthcare The charitable foundation started by Microsoft's Bill Gates has announced 104 grants of $100,000 each to medical researchers to explore what it describe as "bold and largely unproven ways to improve global health |
|
Simcyp spins out 'virtual rat' for drug trials
Tuesday, October 21, 2008 - 08:08 PM - 4 weeks, 1 day ago - Newspaper & TV news - FT.com - Drugs and Healthcare The Sheffield company has launched a computer programme that it claims will mimic testing on animals and can predict the likely response of humans to drug compounds |
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8 – 9 – 10 – 11 – 12 – 13 – 14 – 15 – 16 – 17 – 18 – 19 – 20 – 21 >
News Provided by: FT.com - Drugs and Healthcare